MIB-1 Assessments in breast cancers

This publication has 13 references indexed in Scilit:

• MIB-1 in relation to tumour response and survival in patients with breast cancer treated with primary systemic therapy
  The Breast, 1999
• Proliferating Fraction During Neoadjuvant Chemotherapy of Primary Breast Cancer in Relation to Objective Local Response and Relapse-free Survival
  Acta Oncologica, 1999
• The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by ki-67 labeling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling
  Cancer, 1998
• Effects of short-term pre-operative tamoxifen on steroid receptor and Ki-67 expression in primary breast cancer: an immunocytochemical study.
  International Journal of Oncology, 1998
• Intratumoural heterogeneity of proliferation in invasive breast carcinoma evaluated with MIBI antibody
  The Breast, 1997
• The cell cycle in breast cancer
  APMIS, 1997
• Quantitative Growth Fraction Evaluation with MIB1 and Ki67 Antibodies in Breast Carcinomas
  American Journal of Clinical Pathology, 1994
• Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen
  European Journal Of Cancer, 1994
• Regional heterogeneity in breast carcinoma: Thymidine labelling index, steroid hormone receptors, dna ploidy
  International Journal of Cancer, 1991
• Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.
  Journal of Clinical Pathology, 1986